Download PDF
Thromb Haemost 1994; 72(03): 482-483
DOI: 10.1055/s-0038-1648894
Original Article
Schattauer GmbH Stuttgart

Malformin A Prevents IL-1 Induced Endothelial Changes by Inhibition of Protein Synthesis

P G Bannon
The Heart Research Institute, Sydney, Australia
,
J Dawes
The Heart Research Institute, Sydney, Australia
,
R T Dean
The Heart Research Institute, Sydney, Australia
› Author Affiliations
Further Information

Publication History

Received 29 March 1994

Accepted after revision 28 April 1994

Publication Date:
25 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Curtis R. Curvatures and malformations in bean plants caused by culture filtrate of Aspergillus niger. Plant Physiol 1958; 33: 17-22
    CrossrefPubMedGoogle Scholar
  • 2 Takahashi N, Curtis R. Isolation and characterization of malformin. Plant Physiol 1961; 36: 30-36
    CrossrefPubMedGoogle Scholar
  • 3 Kim K, Yoshida F, Murofushi N, Takahashi N, Curtis R. Structure of malformin A, a phytotoxic metabolite produced by Aspergillus niger. Biosc Biotech Biochem 1993; 57: 240-243
    CrossrefPubMedGoogle Scholar
  • 4 Herbert J, Savi P, Lale A, Laplace M, Baudry N, Emonds-Alt X. Malformin-Al, a potent IL-1 receptor antagonist, inhibits pyrogen-induced expression of tissue factor in human endothelial cells and monocytes. Thromb Haemost 1993; 69: 740
    PubMedGoogle Scholar
  • 5 Richards D, Dean R, Jessup W. Membrane proteins are critical targets in free radical mediated cytolysis. Biochim Biophys Acta 1988; 946: 281-288
    CrossrefPubMedGoogle Scholar
  • 6 Hicks C, Sleigh M, Chesterman C. Quantitation of platelet derived growth factor receptor in cells from human arterial segments. J Immunol Meth 1994; 170: 83-92
    CrossrefPubMedGoogle Scholar